Neuland Laboratories Limited (NSE:NEULANDLAB)
India · Delayed Price · Currency is INR 16,497
-506 (-2.98%)
May 13, 2026, 3:30 PM IST
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 211.11 billion as of May 13, 2026. Its market cap has increased by 25.78% in one year.
Market Cap
211.11B
Enterprise Value
210.57B
Revenue
20.53B
Ranking
n/a
PE Ratio
58.00
Stock Price
16,497.00
Market Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 211.11B, an increase of 62,890.34%. That is a compound annual growth rate of 28.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 218.12B | 11.92% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 389.44B |
| Ajanta Pharma | 382.68B |
| Emcure Pharmaceuticals | 318.13B |
| Gland Pharma | 316.18B |
| Wockhardt | 264.15B |
| Piramal Pharma | 244.52B |
| NATCO Pharma | 216.01B |
| Eris Lifesciences | 190.69B |